Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy
NCT ID: NCT05367869
Last Updated: 2022-05-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2022-06-01
2023-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Liagure Safety in Thyroidectomy With Conventional Thyroidectomy
NCT05684536
Comparison Between Two Techniques During Thyroidectomy (Conventional Dissection Technique and Injection of Methylene Blue Dye Into Inferior Thyroid Artery Technique) Regarding Recurrent Laryngeal Nerve Identification and Preservation
NCT07067814
Impact of Dissection Area on the Clinical Outcome of Endoscopic Thyroidectomy
NCT01338597
Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients
NCT06468696
Evaluation Of Drainless Thyroidectomy For Benign Thyroid Diseases Regarding Surgical Site Complications
NCT06410937
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intraoperative Spraying Methylene Blue In Thyroidectomy
Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy
General anaesthesia ,supine position with hyperextension to the neck Low collar incision to the neck , incision to the skin and platysma muscle and fascia ,upper and lower flaps are developed ,separation of strap muscles and identification of the thyroid gland after freeing of investing fascia Ligation of the middle thyroid vein and ligation and separation of the superior pedicle away from the external laryngeal nerve At this point of operation and before ligation of inferior pedicle methylene blue 0.05% spraying is applied to the field the amount varies according to size of the thyroid lobe and variation in population and neck size Thyroid gland stained by bluish color , recurrent laryngeal nerve not stained or minimally stained so we can avoid injury to it parathyroid glands get red of the stain after about 3 minutes so we can avoid injury to it thyroid gland lose its stain in about 15 minutes so we can remove any residual and decrease residual tissue or recurrence
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Impact of Intraoperative Spraying Methylene Blue In Thyroidectomy
General anaesthesia ,supine position with hyperextension to the neck Low collar incision to the neck , incision to the skin and platysma muscle and fascia ,upper and lower flaps are developed ,separation of strap muscles and identification of the thyroid gland after freeing of investing fascia Ligation of the middle thyroid vein and ligation and separation of the superior pedicle away from the external laryngeal nerve At this point of operation and before ligation of inferior pedicle methylene blue 0.05% spraying is applied to the field the amount varies according to size of the thyroid lobe and variation in population and neck size Thyroid gland stained by bluish color , recurrent laryngeal nerve not stained or minimally stained so we can avoid injury to it parathyroid glands get red of the stain after about 3 minutes so we can avoid injury to it thyroid gland lose its stain in about 15 minutes so we can remove any residual and decrease residual tissue or recurrence
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age more than 15 years
* All pathologies need surgery eg. (mutinodular goiter, malignancy , thyroid nodule,…..etc
* Total thyroidectomy
Exclusion Criteria
* Previous neck surgery or recurrent thyroid surgery
* Subtotal or partial thyroidectomy
* Age less than 15 years
* Preoperative affection to vocal cord
* Preoperative hypocalcaemia
15 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qena Oncology Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Ahmed Orabi
specialist of Surgical Oncology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Remon Elia Lukas, Specialist Surgical Oncology
Role: STUDY_DIRECTOR
Qena Oncology Center
Mohamed Taha Mousa, Resident Surgical Oncology
Role: STUDY_DIRECTOR
Qena Oncology Center
Mina Romany Tawfeek, Specialist General Surgery
Role: STUDY_DIRECTOR
Qena Oncology Center
Abdullah Atyah Ali, Ass.Lecture General Surgery
Role: STUDY_DIRECTOR
Qena Oncology Center--Luxor University
Ali Hassan, Resident General Surgery
Role: STUDY_CHAIR
Qena Oncology Center --Qena University
Mohamed Ahmed Orabi, Specialist Surgical Oncology
Role: PRINCIPAL_INVESTIGATOR
Qena Oncology Center
Amr M Makky, Specialist Surgical Oncology
Role: STUDY_DIRECTOR
Qena Oncology Center- Medical Military Academy
Mostafa Sayedd Abd el Rahaman, Resident Surgical Oncology
Role: STUDY_CHAIR
Qena Oncology Center
Mena Zarief Malaty, Resident General Surgery
Role: STUDY_CHAIR
Qena Oncology Center--Nag hammady Hospital
Hussein El Lithy, Resident General Surgery
Role: STUDY_CHAIR
Qena Oncology Center--Qena General Hospital
Abobakr Mohammed, Resident General Surgery
Role: STUDY_CHAIR
Qena Oncology Center--Qena General Hospital
Mohamed Mahmoud El Zeer, Resident General Surgery
Role: STUDY_CHAIR
Qena Oncology Center- Sohag University
Mahmoud Rabeea Ahmed, Resident General Surgery
Role: STUDY_CHAIR
Qena Oncology Center-Aswan University
Mohamed Abouelmagd Salem, Prof. Surgical Oncology
Role: STUDY_CHAIR
Qena Oncology Center-ٍSouth Egypt Center Institute Assiut University
Mohamed Saeed Ayaty, Ass.Prof. Surgical Oncology
Role: STUDY_CHAIR
Qena Oncology Center-National Cancer Institute Cairo University
Mohamed H Mahran, Ass.Prof. Surgical Oncology
Role: STUDY_CHAIR
Qena Oncology Center-ٍSouth Egypt Center Institute Assiut University
Mohamed Hasan Abdel-Aal, Director of QOC
Role: STUDY_CHAIR
Qena Oncology Center
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Qena Oncology Center
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.